Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study
M. Blake-Cerda, Francisco Javier Lozano Ruíz, Federico Maldonado‐Magos, Dolores de la Mata-Moya, Diego A. Díaz-García, Luis Lara‐Mejía, Zyanya Lucía Zatarain-Barrón, María-Fernanda Cuevas-Góngora, Feliciano Barrón-Barrón, José Francisco Corona-Cruz, Luis Cabrera‐Miranda, Marisol Arroyo‐Hernández, Raquel Gerson, Óscar Arrieta
Topics & Concepts
SABR volatility modelMedicineRadiation therapyClinical endpointLung cancerOncologyInternal medicineRandomized controlled trialEconomicsStochastic volatilityFinancial economicsVolatility (finance)Lung Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisRadiomics and Machine Learning in Medical Imaging